{"entity":{"id":"corbus-pharmaceuticals","kind":"company","name":"Corbus Pharmaceuticals","aka":["Corbus Pharmaceuticals Inc."],"tldr":"Corbus Pharmaceuticals is a United States-based biotechnology company running 2 late-stage cancer trials of CRB-601 monoclonal antibody and CRB-701.","summary":"Corbus Pharmaceuticals, based in Norwood, MA, the United States, is a biotechnology company. Corbus Pharmaceuticals is a pharmaceutical company developing cancer treatments, including a Nectin-4-targeted therapy, alongside an obesity programme. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing CRB-601 monoclonal antibody and CRB-701. The largest, NCT06265727 (A Phase 1/2 Study to Investigate CRB-701 in Solid Tumours), plans to enrol 348 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.corbuspharma.com"},{"label":"ClinicalTrials.gov: trials led by Corbus Pharmaceuticals","url":"https://clinicaltrials.gov/search?lead=Corbus%20Pharmaceuticals%20Inc."}],"tags":["ctgov-sponsor"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":["crb-701"],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial"],"trials":["nct06265727","nct06603844"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Norwood, MA","country":"US","companyType":"biotech","website":"https://www.corbuspharma.com","stage":"public","investors":[],"funding":[]},"route":"/companies/corbus-pharmaceuticals/","neighbours":{"drug":[{"id":"crb-701","kind":"drug","name":"CRB-701","route":"/drugs/crb-701/"}],"term":[{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}],"trial":[{"id":"nct06265727","kind":"trial","name":"A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors","route":"/trials/nct06265727/"},{"id":"nct06603844","kind":"trial","name":"First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.","route":"/trials/nct06603844/"}]}}